Guardant Health Inc. Common Stock vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Guardant Health Inc. Common Stock trades at $168.44 (market cap $22.22B), while GraniteShares 2x Long NVDA Daily ETF trades at $37.32 (market cap $3.56B). The key difference: Guardant Health Inc. Common Stock is far larger — about 6.2× GraniteShares 2x Long NVDA Daily ETF's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, GraniteShares 2x Long NVDA Daily ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.
| GH | NVDL | |
|---|---|---|
Market Cap | $22.22B | $3.56B |
Volume | 1,589,453 | 9,740,643 |
Sector | Health | Leveraged / Inverse |
52-Week High | $187.22 | $43.02 |
52-Week Low | $61.73 | $21.76 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $22.86B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $37.335, down 5.65% on the day. Technical indicators show a bullish overall signal with strong moving average support, though oscillators remain neutral. Recent news highlights Nvidia's continued AI leadership and earnings beats, driving leveraged ETF interest. The ETF aims to deliver 2x daily returns of Nvidia stock, with technical analysis showing support at $36 and resistance at $38-39 levels.
The outlook remains tied to Nvidia's AI dominance and earnings performance. Investment opportunity exists through leveraged exposure to Nvidia's growth trajectory, though risks include daily reset leverage decay and Nvidia's high valuation. Recent SpaceX earnings have reshuffled AI chip trades, creating volatility. The ETF's performance depends on Nvidia maintaining its AI market leadership and execution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →